CN101647022B - 描述蛋白质的构象和根据折叠、整体形状与结构序列对其进行评价的方法、系统及装置 - Google Patents
描述蛋白质的构象和根据折叠、整体形状与结构序列对其进行评价的方法、系统及装置 Download PDFInfo
- Publication number
- CN101647022B CN101647022B CN2008800031642A CN200880003164A CN101647022B CN 101647022 B CN101647022 B CN 101647022B CN 2008800031642 A CN2008800031642 A CN 2008800031642A CN 200880003164 A CN200880003164 A CN 200880003164A CN 101647022 B CN101647022 B CN 101647022B
- Authority
- CN
- China
- Prior art keywords
- protein
- vector
- alpha
- pfsc
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 335
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 332
- 238000000034 method Methods 0.000 title claims abstract description 291
- 239000013598 vector Substances 0.000 claims abstract description 330
- 239000003814 drug Substances 0.000 claims abstract 3
- 150000001413 amino acids Chemical class 0.000 claims description 126
- 229910052799 carbon Inorganic materials 0.000 claims description 98
- 230000012846 protein folding Effects 0.000 abstract description 194
- 238000004458 analytical method Methods 0.000 abstract description 21
- 238000004422 calculation algorithm Methods 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 11
- 238000013459 approach Methods 0.000 abstract description 10
- 238000013461 design Methods 0.000 abstract description 6
- 102000039446 nucleic acids Human genes 0.000 abstract description 4
- 108020004707 nucleic acids Proteins 0.000 abstract description 4
- 150000007523 nucleic acids Chemical class 0.000 abstract description 4
- 102000003886 Glycoproteins Human genes 0.000 abstract description 2
- 108090000288 Glycoproteins Proteins 0.000 abstract description 2
- 235000014633 carbohydrates Nutrition 0.000 abstract description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 description 274
- 235000001014 amino acid Nutrition 0.000 description 117
- 239000012634 fragment Substances 0.000 description 102
- 210000004027 cell Anatomy 0.000 description 60
- 238000013178 mathematical model Methods 0.000 description 55
- 230000008569 process Effects 0.000 description 36
- 125000003275 alpha amino acid group Chemical group 0.000 description 27
- 230000014509 gene expression Effects 0.000 description 26
- 230000001788 irregular Effects 0.000 description 20
- ZXKXJHAOUFHNAS-FVGYRXGTSA-N (S)-fenfluramine hydrochloride Chemical compound [Cl-].CC[NH2+][C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 ZXKXJHAOUFHNAS-FVGYRXGTSA-N 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 230000036961 partial effect Effects 0.000 description 13
- 125000004429 atom Chemical group 0.000 description 12
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 10
- RUXQWZJWMCHCHH-IZZDOVSWSA-N [(e)-1-pyridin-2-ylethylideneamino]urea Chemical compound NC(=O)N\N=C(/C)C1=CC=CC=N1 RUXQWZJWMCHCHH-IZZDOVSWSA-N 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 230000007704 transition Effects 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 8
- 208000024827 Alzheimer disease Diseases 0.000 description 7
- 238000002441 X-ray diffraction Methods 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000194108 Bacillus licheniformis Species 0.000 description 5
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 5
- 102000017278 Glutaredoxin Human genes 0.000 description 5
- 108050005205 Glutaredoxin Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010039966 Senile dementia Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000009795 derivation Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 235000019256 formaldehyde Nutrition 0.000 description 4
- 230000011218 segmentation Effects 0.000 description 4
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 102000004093 Ribosomal protein S15 Human genes 0.000 description 3
- 108090000530 Ribosomal protein S15 Proteins 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009510 drug design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- ZMYKITJYWFYRFJ-UHFFFAOYSA-N 4-oxo-4-(2-phenylethylamino)butanoic acid Chemical compound OC(=O)CCC(=O)NCCC1=CC=CC=C1 ZMYKITJYWFYRFJ-UHFFFAOYSA-N 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- -1 Gibrat JF Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 238000000367 ab initio method Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000008876 conformational transition Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000000455 protein structure prediction Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108020005087 unfolded proteins Proteins 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
PFSC向量 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | $ |
α-螺旋 | X | ||||||||||||||||||||||||||
β-折叠 | X | ||||||||||||||||||||||||||
类α-螺旋 | X | X | X | X | X | X | |||||||||||||||||||||
类β-折叠 | X | X | X | X | X | X | |||||||||||||||||||||
伸展距离c1 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
伸展距离c2 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
伸展距离c3 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
C-端α-螺旋 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
N-端α-螺旋 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
C-端β-折叠 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
N-端β-折叠 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
C-端不规则结构 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
N-端不规则结构 | X | X | X | X | X | X | X | X | X | ||||||||||||||||||
N-端Cap α-螺旋 | X | X | X | X | |||||||||||||||||||||||
C-端Cap α-螺旋 | X | X | X | X | X | ||||||||||||||||||||||
N-端Cap β-折叠 | X | X | X | X | |||||||||||||||||||||||
C-端Cap β-折叠 | X | X | X | X |
Protein | Residues | Methods | Structural Assignment |
1A32 | 12-24 | SequencePDBDSSPSTRIDEPBPFSCPFSCV | QFKVHENDTG SPEaa----------aHCCCCCCCCCCHHHHCCCCCCCCCHHmmgcehiopafklAAJVPYHBBVJVAα-αα-αα-ββ-αα-**-αα-αβ-ββ-ββ-αα-ββ-αα-α |
1A32 | 43-51 | SequencePDBDSSPSTRIDEPBPFSCPFSCV | VHKKDHHSRaa-----aaHCCCCCHHHHCCCCCHHHmmmbmklmmAJVABVAAAα-αα-ββ-αα-αβ-ββ-αα-αα-αα-α |
4BLM | 49-57 | SequencePDBDSSPSTRIDESSBPFSCPFSCV | LDTGTNRTVbbb--bbbbEETTT--EEETTTT--EEbizzhtbbbBBVAABBBBβ-ββ-ββ-αα-αα-αβ-ββ-ββ-ββ-β |
4BLM | 91-110 | SequencePDBDSSPSTRIDESSBPFSCPFSCV | LNQRITYTRDDLVNYNPITEaa-------------aaaaaGG-EE---GGG--S-TTGGGG-EE---GGG-TTTTTTGGahtbbbbizzhtizhizzaaAAHBBBBWYAAJWYJBVDAAα-αα-αα-αβ-ββ-ββ-ββ-ββ-α*-αα-αα-αα-ββ-α*-αα-ββ-ββ-αα-αα-αα- |
4BLM | 153-169 | SequencePDBDSSP | RKIGDEVTNPERFEPELa-----bbbbb-aaa a aHHTT-SS-------TTG |
STRIDESSBPFSCPFSCV | HHH-TTTT B---TTTGGaahhizhtbbbbizzaaAADJBVAJBBVAPYAAAα-αα-αα-αα-ββ-ββ-αα-αα-ββ-ββ-ββ-αα-αα-**-αα-αα-αα-α | ||
4BLM | 169-181 | SequencePDBDSSPSTRIDESSBPFSCPFSCV | LNEVNPGETQDT Saaaa-----bbbbGG---TT--TTEEGG--TTTTTTTEEahttizhtizhtbAAJBWYABBAABUα-αα-αα-ββ-ββ-α*-αα-αβ-ββ-ββα-αα-αβ-ββ-α |
4BLM | 193-203 | SequencePDBDSSPSTRIDESSBPFSCPFSCV | FALEDKLPSEKaaaa----aaaHHHSSSS-HHHHHH-TTTTHHHaahhzhhizzaDDAPYAAHAAAα-αα-αα-αα-**-αα-αα-αα-αα-αα-αα-α |
4BLM | 212-222 | SequencePDBDSSPSTRIDESSBPFSCPFSCV | KRNTTGDALIRa-----aaaaaHT-SS-TTTGGHHTTTTTTTGGahtzzaaaazaAJBVAAAAQZAα-αα-ββ-ββ-αα-αα-αα-αα-αα-**-αα-α |
4BLM | 266-278 | SEQUENCEPDBDSSPSTRIDESSBPFSCPFSCV | SRDKKDAKYDDKLbbb-------aaaE-SSTT----THHE--TTTT---HHHbibizhtbbizzaBBHJVJBBBBVAAβ-ββ-βα-αα-ββ-αα-ββ-ββ-ββ-ββ-ββ-αα-αα-α |
Claims (3)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89852907P | 2007-01-31 | 2007-01-31 | |
US60/898,529 | 2007-01-31 | ||
US409407P | 2007-11-23 | 2007-11-23 | |
US61/004,094 | 2007-11-23 | ||
US6277508P | 2008-01-29 | 2008-01-29 | |
US61/062,775 | 2008-01-29 | ||
PCT/US2008/001159 WO2008094547A2 (en) | 2007-01-31 | 2008-01-30 | Methods, systems, algorithyms and means for describing the possible conformations of actual and theoretical proteins and for evaluating actual and theoretical proteins with respect to folding, overall shape and structural motifs |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101647022A CN101647022A (zh) | 2010-02-10 |
CN101647022B true CN101647022B (zh) | 2012-07-18 |
Family
ID=39674699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008800031642A Active CN101647022B (zh) | 2007-01-31 | 2008-01-30 | 描述蛋白质的构象和根据折叠、整体形状与结构序列对其进行评价的方法、系统及装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8818737B2 (zh) |
EP (1) | EP2118795A4 (zh) |
JP (1) | JP2010517195A (zh) |
CN (1) | CN101647022B (zh) |
WO (1) | WO2008094547A2 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014144963A1 (en) * | 2013-03-15 | 2014-09-18 | Alexandre Zanghellini | Automated method of computational enzyme identification and design |
WO2015161243A2 (en) * | 2014-04-17 | 2015-10-22 | Synthetic Biologics, Inc. | Beta-lactamases with improved properties for therapy |
CN105260626B (zh) * | 2015-09-25 | 2017-11-14 | 麦科罗医药科技(武汉)有限公司 | 蛋白质结构空间构象的全信息预测方法 |
CN105205351B (zh) * | 2015-09-25 | 2017-11-14 | 麦科罗医药科技(武汉)有限公司 | 一种药物靶标的高通量检索方法 |
CN107463793A (zh) * | 2017-06-21 | 2017-12-12 | 南京迈格罗医药科技有限公司 | 抗体互补决定区构象指纹数据库 |
EP3638801A4 (en) | 2017-07-26 | 2021-03-24 | Yacyshyn, Vincent | DISPOSAL OF POLYPHENOLS CONTAMINANTS FROM STARTING CHARGE POLYPHENOLS |
JP7257663B2 (ja) * | 2017-12-06 | 2023-04-14 | 学校法人近畿大学 | 生体高分子立体構造表示装置、プログラムおよび表示方法 |
CN109390035B (zh) * | 2018-08-29 | 2021-04-06 | 浙江工业大学 | 一种基于局部结构比对的蛋白质构象空间优化方法 |
CN112585685B (zh) * | 2018-09-21 | 2024-10-01 | 渊慧科技有限公司 | 使用估计相似性的几何神经网络来预测蛋白结构 |
US11173187B2 (en) | 2018-11-13 | 2021-11-16 | Immortazyme Company Ltd. | Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition |
CN111180021B (zh) * | 2019-12-26 | 2022-11-08 | 清华大学 | 一种蛋白质结构势能函数的预测方法 |
JP7116442B2 (ja) | 2020-03-06 | 2022-08-10 | シェンヂェン ジンタイ テクノロジー カンパニー リミテッド | 分子の立体配座空間解析のためのポテンシャルエネルギー曲面スキャン方法およびシステム |
CN116153435B (zh) * | 2023-04-21 | 2023-08-11 | 山东大学齐鲁医院 | 基于上色与三维结构的多肽预测方法及系统 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1328601A (zh) * | 1998-08-25 | 2001-12-26 | 斯克利普斯研究院 | 预测蛋白质功能的方法和系统 |
CN1602487A (zh) * | 2001-12-10 | 2005-03-30 | 富士通株式会社 | 蛋白质立体结构的预测装置及其预测方法 |
CN1632817A (zh) * | 2004-12-28 | 2005-06-29 | 南京大学 | 一种蛋白质二级结构预测方法 |
CN1672160A (zh) * | 2002-05-20 | 2005-09-21 | 埃博马可西斯公司 | 在计算机上产生和筛选蛋白质文库 |
CN1849611A (zh) * | 2003-09-08 | 2006-10-18 | Acgt前基因组公司 | 建立和分析氨基酸序列构象的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3483374B2 (ja) * | 1995-12-01 | 2004-01-06 | 富士通株式会社 | タンパク質立体構造の行列表現方法および部分構造抽出方法並びにタンパク質の立体構造解析システム |
-
2008
- 2008-01-30 WO PCT/US2008/001159 patent/WO2008094547A2/en active Search and Examination
- 2008-01-30 JP JP2009548282A patent/JP2010517195A/ja active Pending
- 2008-01-30 EP EP08724912A patent/EP2118795A4/en not_active Withdrawn
- 2008-01-30 US US12/524,572 patent/US8818737B2/en not_active Expired - Fee Related
- 2008-01-30 CN CN2008800031642A patent/CN101647022B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1328601A (zh) * | 1998-08-25 | 2001-12-26 | 斯克利普斯研究院 | 预测蛋白质功能的方法和系统 |
CN1602487A (zh) * | 2001-12-10 | 2005-03-30 | 富士通株式会社 | 蛋白质立体结构的预测装置及其预测方法 |
CN1672160A (zh) * | 2002-05-20 | 2005-09-21 | 埃博马可西斯公司 | 在计算机上产生和筛选蛋白质文库 |
CN1849611A (zh) * | 2003-09-08 | 2006-10-18 | Acgt前基因组公司 | 建立和分析氨基酸序列构象的方法 |
CN1632817A (zh) * | 2004-12-28 | 2005-06-29 | 南京大学 | 一种蛋白质二级结构预测方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2118795A4 (en) | 2010-07-07 |
US8818737B2 (en) | 2014-08-26 |
EP2118795A2 (en) | 2009-11-18 |
JP2010517195A (ja) | 2010-05-20 |
US20090319193A1 (en) | 2009-12-24 |
CN101647022A (zh) | 2010-02-10 |
WO2008094547A3 (en) | 2008-12-18 |
WO2008094547A2 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101647022B (zh) | 描述蛋白质的构象和根据折叠、整体形状与结构序列对其进行评价的方法、系统及装置 | |
Güntert | Automated structure determination from NMR spectra | |
Boniecki et al. | SimRNA: a coarse-grained method for RNA folding simulations and 3D structure prediction | |
Wood et al. | CCBuilder: an interactive web-based tool for building, designing and assessing coiled-coil protein assemblies | |
Kolodny et al. | Protein structure comparison: implications for the nature of ‘fold space’, and structure and function prediction | |
Shatsky et al. | A method for simultaneous alignment of multiple protein structures | |
Shen et al. | Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks | |
Ritchie et al. | Fast protein structure alignment using Gaussian overlap scoring of backbone peptide fragment similarity | |
Cassioli et al. | An algorithm to enumerate all possible protein conformations verifying a set of distance constraints | |
Kumar et al. | HELANAL-Plus: a web server for analysis of helix geometry in protein structures | |
Dror et al. | Multiple structural alignment by secondary structures: algorithm and applications | |
Randić et al. | Milestones in graphical bioinformatics | |
CN109300501B (zh) | 蛋白质三维结构预测方法及用其构建的预测云平台 | |
Cosgrove et al. | A novel method of aligning molecules by local surface shape similarity | |
Huang et al. | Similarity studies of DNA sequences based on a new 2D graphical representation | |
Pei et al. | Random forest refinement of the KECSA2 knowledge-based scoring function for protein decoy detection | |
WO2013054192A2 (en) | Systems and methods for generation of context-specific, molecular field-based amino acid substitution matrices | |
Planas-Iglesias et al. | AggreProt: a web server for predicting and engineering aggregation prone regions in proteins | |
US20130090247A1 (en) | Methods and systems for identification of binding pharmacophores | |
Poluri et al. | Prediction, analysis, visualization, and storage of protein–protein interactions using computational approaches | |
Khalife et al. | Secondary structure assignment of proteins in the absence of sequence information | |
Wu et al. | OPUS-Dom: applying the folding-based method VECFOLD to determine protein domain boundaries | |
Pei et al. | Pair Potentials as Machine Learning Features | |
JP2007505372A (ja) | アミノ酸配列の立体構造を確定し、分析する方法 | |
US20070244651A1 (en) | Structure-Based Analysis For Identification Of Protein Signatures: CUSCORE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MICRO PHARMACEUTICAL TECHNOLOGY (WUHAN) CO., LTD. Free format text: FORMER OWNER: SANGDIYA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CLC Effective date: 20120529 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 430075 WUHAN, HUBEI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120529 Address after: 430075, B5, 666 hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, Wuhan Applicant after: Mccollow Pharmaceutical Technology (Wuhan) Co.,Ltd. Address before: 201203 building, building 388, 8 Galileo Road, Zhangjiang hi tech park, Shanghai, Pudong, China Applicant before: Sandia Pharmaceutical Technology (Shanghai) Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231115 Address after: Room E and F, 26th Floor, No. 828-838 Zhangyang Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, 201208 Patentee after: McCullough Biotechnology (Shanghai) Co.,Ltd. Address before: 430075 B5, No. 666 Gaoxin Avenue, Wuhan Donghu Development Zone, Wuhan City, Hubei Province Patentee before: Mccollow Pharmaceutical Technology (Wuhan) Co.,Ltd. |